AI assistant
Sending…
NovoCure Ltd — Director's Dealing 2023
Mar 6, 2023
31949_dirs_2023-03-06_3f3dda77-2817-45d3-ba4b-3b353ebdb702.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2023-03-03
Reporting Person: Weinberg Uri (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-03-03 | Ordinary Shares | A | 28830.00 | $0.00 | Acquired | 85108.00 | Direct |
| 2023-03-03 | Ordinary Shares | A | 3936.00 | $0.00 | Acquired | 89044.00 | Direct |
Footnotes
F1: Represents vesting of performance-based restricted stock units.
More from NovoCure Ltd
Proxy Solicitation & Information Statement
2026
May 21
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 9
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3